Shilpa Medicare Ltd

SHILPAMED

Company Profile

  • Business description

    Shilpa Medicare Ltd is a specialty and generic drug manufacturer. The company deals in high-quality Active Pharmaceutical Ingredients (APIs), Intermediates, Formulations, New Drug Delivery Systems, Peptides, Biotech products, and Specialty Chemicals etc. Its portfolio comprises various oncology and non-oncology-related APIs such as anastrozole, acebrophylline, busulphan, decitabine, etc, and finished dosage formulations such as apremilast tablets, clofarabine injection, docetaxel injection, etc., in various therapy areas. Its reporting segments are: Pharmaceutical product and services, which derive maximum revenue, Power sales, and Others. Geographically, the company generates maximum revenue from India, followed by Europe, the United States of America, and the Rest of the world.

  • Contact

    Hyderabad Road
    No. 12-6-214/A-1, Shilpa House
    RaichurKA584135
    IND

    T: +91 8532238704

    https://www.vbshilpa.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    998

Stocks News & Analysis

stocks

Chart of the Week: Has gold reached bear market territory?

Investors are facing a shifting landscape.
stocks

ASX share benefiting from favourable industry trends

We anticipate further earnings growth.
stocks

Fair value upgrade for this ASX income player

Headwinds in listed energy stocks likely to have passed

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,885.6059.900.68%
CAC 407,961.80144.861.85%
DAX 4023,190.98510.942.25%
Dow JONES (US)46,341.511,125.372.49%
FTSE 10010,369.23192.781.89%
HKSE25,294.03505.892.04%
NASDAQ21,590.63795.993.83%
Nikkei 22553,739.682,675.965.24%
NZX 50 Index12,825.8786.24-0.67%
S&P 5006,528.52184.802.91%
S&P/ASX 2008,671.8053.100.62%
SSE Composite Index3,948.5556.691.46%

Market Movers